Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
omega-3 fatty acids (Instituto Mexicano del Seguro Social)
- Development stage
- Unknown
- Lead developer
- Instituto Mexicano del Seguro Social
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Omega-3 fatty acids are essential polyunsaturated fatty acids, primarily eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which serve as precursors for anti-inflammatory eicosanoids and specialized pro-resolving mediators. In a clinical trial conducted by the Coordinación de Investigación en Salud at the Instituto Mexicano del Seguro Social (IMSS) in Mexico, a daily dose of 2.4 grams of omega-3 fatty acids (Zonelabs) was investigated for its potential to reduce oxidative stress in HIV-seropositive patients undergoing highly active antiretroviral therapy (HAART). The study specifically targeted markers such as nitric oxide catabolites, lipoperoxides, and glutathione. While the intervention successfully reduced serum triglyceride levels, it did not show a significant effect on the primary oxidative stress endpoints compared to placebo.
- Brand names
- Zonelabs
- Other names
- omega-3 polyunsaturated fatty acidsomega3 polyunsaturated fatty acidsomega 3 polyunsaturated fatty acidsn-3 PUFAsn3 PUFAsn 3 PUFAsfish oil
02
Targets
PPARG (Peroxisome proliferator-activated receptor gamma)PPARA (Peroxisome proliferator-activated receptor alpha)
Beyond the preview
Go deeper on omega-3 fatty acids (Instituto Mexicano del Seguro Social).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on omega-3 fatty acids (Instituto Mexicano del Seguro Social).